EPISODE · Feb 1, 2021 · 11 MIN
Alimera Sciences, Inc. Discusses Its 2021 Global Expansion Strategy with The Stock Day Podcast
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Alimera Sciences, Inc. (ALIM)(“the Company”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. President and CEO of the Company, Rick Eiswirth, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Embed this episode
NOW PLAYING
Alimera Sciences, Inc. Discusses Its 2021 Global Expansion Strategy with The Stock Day Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.